Literature DB >> 24522676

Protecting infants from pertussis.

Meghan Gilley1, Ran D Goldman.   

Abstract

QUESTION: With the increased rate of pertussis in children, several families have asked me about ways to protect their young infants from pertussis infection. What should I recommend to these families? ANSWER: Pertussis is a preventable disease that is endemic worldwide. In adults pertussis causes a mild coldlike illness followed by a persistent cough. In young infants it can cause apnea, seizures, encephalopathy, bronchopneumonia, and death. Infants younger than 4 months of age account for 86% of all deaths due to pertussis. Cocooning, the vaccination of adults in close contact with infants, is recommended by numerous global and national agencies but is likely to prevent only 20% of cases of pertussis in infants. Vaccination during pregnancy is more effective but not yet approved in Canada. Vaccination at birth has not been shown to be consistently effective and therefore is not recommended at this time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522676      PMCID: PMC3922557     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  18 in total

1.  Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

Authors:  L Coudeville; A van Rie; P Andre
Journal:  Epidemiol Infect       Date:  2007-07-05       Impact factor: 2.451

2.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-10-21       Impact factor: 17.586

3.  The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Elodie P Sonfack Tsafack; Manale Ouakki; Linda Hoang; Gaston De Serres
Journal:  Clin Infect Dis       Date:  2011-12-08       Impact factor: 9.079

4.  Efficacy of an acellular pertussis vaccine among adolescents and adults.

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Hang Lee; John Treanor; David P Greenberg; Wendy Keitel; Stephen Barenkamp; David I Bernstein; Robert Edelman; Kathryn Edwards
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

Review 5.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

Review 6.  Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

Authors:  K E Wiley; Y Zuo; K K Macartney; P B McIntyre
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

Review 7.  Pertussis in early infancy: disease burden and preventive strategies.

Authors:  Peter McIntyre; Nicholas Wood
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

8.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

View more
  4 in total

1.  Response.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-06       Impact factor: 3.275

2.  NACI update on pertussis vaccination in pregnancy.

Authors:  Bryna Warshawsky
Journal:  Can Fam Physician       Date:  2014-06       Impact factor: 3.275

3.  Anti-FIM and Anti-FHA Antibodies Inhibit Bordetella pertussis Growth and Reduce Epithelial Cell Inflammation Through Bacterial Aggregation.

Authors:  Issaka Yougbare; Adam McTague; Liwei He; Christopher H Choy; Jin Su; Beata Gajewska; Ali Azizi
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

4.  Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015.

Authors:  B Born; A Coombs; V Ryan; M LaFreniere; L Earle; S Fleming; A Fitzgerald; F Atherton
Journal:  Can Commun Dis Rep       Date:  2017-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.